Table 1.

Triptan agents with Paediatric Health Canada and/or FDA Approval

Triptan	Route	Approval agency (year approved)	Age	Dose
Rizatriptan	Oral Dissolving Tablet	FDA (2011)	≥6 years old	5 mg (<40 kg), 10 mg (≥40 kg)
Zolmitriptan	Nasal Spray (Oral dissolving tablet not approved)	FDA (2015)	≥12 years old	2.5 mg, 5 mg
Almotriptan	Oral Tablet	Health Canada (2011), FDA (2009)	≥12 years old	12.5 mg
Sumatriptan	Nasal Spray	EMA (2015)	≥12 years old (Age 6 years old, AAN 2004 statement)	10 mg (20 mg, not approved)
Sumatriptan + Naproxen Sodium (Not available in Canada)	Oral tablet	FDA (2015)	≥ 12 years old	Sumatriptan 85 mg + Naproxen Sodium 500 mg

Data taken from refs. (5,6,7)

EMA European Medicines Agency; FDA Food and Drug Administration; AAN American Academy of Neurology